Show simple item record

dc.contributor.authorBarceló-Coblijn, Gwendolyn*
dc.contributor.authorAmedei, Amedeo*
dc.date.accessioned2021-02-11T16:33:42Z
dc.date.available2021-02-11T16:33:42Z
dc.date.issued2019*
dc.date.submitted2019-12-09 11:49:16*
dc.identifier42626*
dc.identifier.urihttps://directory.doabooks.org/handle/20.500.12854/50545
dc.description.abstract[Increasing evidence suggests that microbiota and especially the gut microbiota (the microbes inhabiting the gut including bacteria, archaea, viruses, and fungi) plays a key role in human physiology and pathology. Recent findings indicate how dysbiosis—an imbalance in the composition and organization of microbial populations—could severely impact the development of different medical conditions (from metabolic to mood disorders), providing new insights into the comprehension of diverse diseases, such as IBD, obesity, asthma, autism, stroke, diabetes, and cancer. Given that microbial cells in the gut outnumber host cells, microbiota influences human physiology both functionally and structurally. Microbial metabolites bridge various—even distant—areas of the organism by way of the immune and hormone system. For instance, it is now clear that the mutual interaction between the gastrointestinal tract and the brain (gut–brain axis), often involves gut microbiota, indicating that the crosstalk between the organism and its microbial residents represents a fundamental aspect of both the establishment and maintenance of healthy conditions. Moreover, it is crucial to recognize that beyond the intestinal tract, microbiota populates other host organs and tissues (e.g., skin and oral mucosa). We have edited this eBook with the aim of publishing manuscripts focusing on the impact of microbiota in the development of different diseases and their associated treatments.]*
dc.languageEnglish*
dc.subjectR5-920*
dc.subjectRC31-1245*
dc.subject.othergastrointestinal diseases*
dc.subject.othersterile inflammation*
dc.subject.othern/a*
dc.subject.otherStaphylococcus spp.*
dc.subject.otheretiopathogenesis*
dc.subject.othercolitis*
dc.subject.otherEscherichia coli*
dc.subject.otherbacteriophages*
dc.subject.otheratopic dermatitis*
dc.subject.otherintravenous immunoglobulin G*
dc.subject.otheradaptive immunity*
dc.subject.other16S rRNA gene*
dc.subject.othervaginal microbiota*
dc.subject.othermodularity*
dc.subject.otherinnate immunity*
dc.subject.othergut-liver axis*
dc.subject.otherdisease activity*
dc.subject.otherimmune system*
dc.subject.othercytokines*
dc.subject.othercommensals*
dc.subject.otherStaphylococcus aureus*
dc.subject.otherdysbiosis*
dc.subject.otherfecal transplantation*
dc.subject.otherTLR mimicry*
dc.subject.otheretanercept*
dc.subject.otherdextran sulfate sodium*
dc.subject.otherCAR T-cell*
dc.subject.other3-dihydroxy-4-methoxyBenzaldehyde*
dc.subject.otherchemo free treatment*
dc.subject.otherStaphylococcus epidermis*
dc.subject.otherrheumatoid arthritis*
dc.subject.othermicrobiome*
dc.subject.otherco-occurrence network*
dc.subject.otherimmune epigenetics*
dc.subject.other2*
dc.subject.otherautoimmunity*
dc.subject.othersuperoxide dismutase*
dc.subject.otherprecision medicine*
dc.subject.othermetabolism*
dc.subject.otheradoptive cell transfer (ACT)*
dc.subject.othergut barrier*
dc.subject.otherantibiotics*
dc.subject.othercheckpoint inhibitors*
dc.subject.otherprobiotics*
dc.subject.othermicrobiota*
dc.subject.otherCandida albicans*
dc.subject.otherEnterococcus faecalis*
dc.subject.otherchronic liver diseases*
dc.subject.otherTCR*
dc.subject.otheranaerobic bacteria*
dc.subject.otherHSV2*
dc.subject.otherbacteriocins*
dc.subject.othermethotrexate*
dc.subject.othermicrobial interactions*
dc.subject.otherT cells*
dc.subject.othervirus*
dc.subject.othermice*
dc.subject.otherlymphoid malignancies*
dc.subject.otherHPV*
dc.subject.othermacrophages*
dc.subject.otheranti-TNF-?*
dc.subject.otherinflammation*
dc.subject.otherchondroitin sulfate disaccharide*
dc.subject.otherimmunotherapy*
dc.subject.othergenomics*
dc.subject.otherimmuno-oncology*
dc.subject.otherdiet*
dc.subject.otheraerobic bacteria*
dc.subject.otherimmunological niche*
dc.subject.othermelanin*
dc.subject.otherhealth*
dc.subject.otherchemokines*
dc.subject.othergut microbiota*
dc.subject.othercutaneous immunity*
dc.subject.otherHIV*
dc.subject.otherTIL*
dc.subject.othercancer*
dc.subject.otherglobal network*
dc.titleThe Interplay of Microbiome and Immune Response in Health and Diseases*
dc.typebook
oapen.identifier.doi10.3390/books978-3-03921-647-5*
oapen.relation.isPublishedBy46cabcaa-dd94-4bfe-87b4-55023c1b36d0*
oapen.relation.isbn9783039216475*
oapen.relation.isbn9783039216468*
oapen.pages206*
oapen.edition1st*


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

https://creativecommons.org/licenses/by-nc-nd/4.0/
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by-nc-nd/4.0/